This article first appeared with Targeted Oncology™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...
Soft tissue sarcomas are a group of rare cancers that can occur in almost any part of the body and develop in tissues like muscle, fat, and nerves. The most common types are leiomyosarcoma, ...
Ravin Ratan, MD, MEd, of The University of Texas MD Anderson Cancer Center, explains the origins of soft tissue sarcomas within the body—which account for 1% of cancers in adult patients—how they are ...
At two years of follow-up, fewer than 20% of evaluable patients developed grade 2 or higher radiation-related toxic effects, ...
Moderately hypofractionated definitive radiotherapy may be used as a radical treatment option in patients with inoperable non ...
Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS). Efficacy and safety of anlotinib combined with anthracycline and ifosfamide followed by anlotinib ...
For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...
Undifferentiated small round cell sarcoma (USRCS) is a type of cancer affecting the bones and soft tissue. This rare form of cancer can affect people of all ages. USRCS is an extremely rare sarcoma ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel (Tecelra ®, also known as afami-cel) for the treatment of adults with a rare ...
Lumps and bumps are common in childhood, but when they form in soft tissue without an obvious cause, they could be pediatric soft tissue sarcoma (STS). In children, cancer that forms in the soft ...
Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...